These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34039905)

  • 21. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
    Wu Y; Fang F; Lai W; Li C; Li L; Liu Q; Lu J; Pang X; Sun J; Shi X; Picaut P; Prygova I; Andriopoulos B; Sun Q
    Aesthetic Plast Surg; 2023 Feb; 47(1):351-364. PubMed ID: 36536093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin.
    Dabrowski E; Bonikowski M; Gormley M; Volteau M; Picaut P; Delgado MR
    Pediatr Neurol; 2018 May; 82():44-49. PubMed ID: 29625849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A for facial wrinkles.
    Camargo CP; Xia J; Costa CS; Gemperli R; Tatini MD; Bulsara MK; Riera R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011301. PubMed ID: 34224576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abobotulinumtoxina injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.
    Lejeune T; Khatkova S; Turner-Stokes L; Picaut P; Maisonobe P; Balcaitiene J; Boyer FC
    J Rehabil Med; 2020 Jun; 52(6):jrm00068. PubMed ID: 32451555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Video enhanced visual analysis of hemiparetic gait muscle selection: A pilot study.
    Esquenazi A
    Toxicon; 2023 Jun; 228():107112. PubMed ID: 37060926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AbobotulinumtoxinA: A Review in Pediatric Lower Limb Spasticity.
    Syed YY
    Paediatr Drugs; 2017 Aug; 19(4):367-373. PubMed ID: 28623614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum Toxin Injections and Electrical Stimulation for Spastic Paresis Improve Active Hand Function Following Stroke.
    Lee JM; Gracies JM; Park SB; Lee KH; Lee JY; Shin JH
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30366407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy.
    Chang CL; Munin MC; Skidmore ER; Niyonkuru C; Huber LM; Weber DJ
    Arch Phys Med Rehabil; 2009 Sep; 90(9):1462-8. PubMed ID: 19735772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.
    Johnston K; Danchenko N; Hansen R; Dinet J; Liovas A; Armstrong A; Bains S; Sullivan SD
    J Med Econ; 2020 Jun; 23(6):631-640. PubMed ID: 31985313
    [No Abstract]   [Full Text] [Related]  

  • 32. Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies.
    Esquenazi A; Delgado MR; Hauser RA; Picaut P; Foster K; Lysandropoulos A; Gracies JM
    Front Neurol; 2020; 11():576117. PubMed ID: 33101184
    [No Abstract]   [Full Text] [Related]  

  • 33. The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
    Danchenko N; Johnston KM; Whalen J
    J Med Econ; 2022; 25(1):919-929. PubMed ID: 35730362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy.
    Delgado MR; Bonikowski M; Carranza J; Dabrowski E; Matthews D; Russman B; Tilton A; Velez JC; Grandoulier AS; Picaut P
    J Child Neurol; 2017 Nov; 32(13):1058-1064. PubMed ID: 28914131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.
    Rekand T; Biering-Sörensen B; He J; Vilholm OJ; Christensen PB; Ulfarsson T; Belusa R; Ström T; Myrenfors P; Maisonobe P; Dalager T
    BMJ Open; 2019 May; 9(5):e024340. PubMed ID: 31061021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guided Self-rehabilitation Contract vs conventional therapy in chronic peripheral facial paresis: VISAGE, a multicenter randomized controlled trial.
    Baude M; Guihard M; Gault-Colas C; Bénichou L; Coste A; Méningaud JP; Schmitz D; Natella PA; Audureau E; Gracies JM
    BMC Neurol; 2023 Apr; 23(1):148. PubMed ID: 37038105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound Structural Changes in Triceps Surae After a 1-Year Daily Self-stretch Program: A Prospective Randomized Controlled Trial in Chronic Hemiparesis.
    Pradines M; Ghedira M; Portero R; Masson I; Marciniak C; Hicklin D; Hutin E; Portero P; Gracies JM; Bayle N
    Neurorehabil Neural Repair; 2019 Apr; 33(4):245-259. PubMed ID: 30900512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy.
    Kaňovský P; Heinen F; Schroeder AS; Chambers HG; Dabrowski E; Geister TL; Hanschmann A; Martinez-Torres FJ; Pulte I; Banach M; Gaebler-Spira D
    J Pediatr Rehabil Med; 2022; 15(1):113-127. PubMed ID: 34957963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol.
    Esquenazi A; Ayyoub Z; Verduzco-Gutierrez M; Maisonobe P; Otto J; Patel AT
    Adv Ther; 2021 Nov; 38(11):5623-5633. PubMed ID: 34562231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.